Low Vitamin B12 Levels Linked to a Shrinking Brain
Low levels of vitamin B12 in elderly people may cause the brain to shrink. Continue reading
Combining Alzheimer’s Drugs May Offer Sustained Benefits
A new study shows that combining two kinds of Alzheimer’s drugs may provide the greatest benefits in helping to delay the progression of symptoms. Continue reading
Alzheimer’s Drug PBT2 Shows Promise in Early Testing
Men and women with early Alzheimer’s disease showed modest benefits from PBT2, an experimental drug now in mid-stage testing. Continue reading
New Drugs for Alzheimer’s Work in Novel Ways
A new class of drugs called gamma-secretase modulators give doctors hope that these medications may offer effective new treatments for Alzheimer’s. Continue reading
Experimental Alzheimer’s Drug Advances to Late-Stage Trials
Bapineuzumab, an experimental Alzheimer’s drug now undergoing testing, showed promise in mid-stage trials in people with early to moderate Alzheimer’s disease. Continue reading
Can an Advil a Day Keep Alzheimer’s Away?
Studies are conflicted on whether anti-inflammatories lower dementia risk. Continue reading
Antipsychotics Pose Risks
Even Short-Term Use of Psychosis-Fighting Drugs Poses Dangers for Those With Alzheimer’s Continue reading
Bright Lights and Melatonin May Aid Alzheimer’s Care
Use of bright lighting in senior care facilities was associated with improvement in dementia symptoms. Continue reading
Alzheimer’s Drug Flurizan Fails in Late-Stage Testing
Flurizan, an experimental drug that had been undergoing late-stage testing, failed… Continue reading
Experimental Drug Flurizan May Slow Decline of Mild Alzheimer’s
Patients taking tarenflurbil had less functional decline in mid-size clinical trial. Continue reading
